The Peptide CDMOs — Making the GLP-1 Molecules · The GLP-1 & Bio Supply Chain — Peptides, Bioprocessing & Diagnostics
LONN.SW
Lonza GroupForeign listing — not directly tradable in a US brokerage. Editorial detail only.
Largest CDMO globally — small molecules, biologics, cell/gene, peptides. Broader exposure than pure-play peptide names.
What they do
Largest CDMO globally — handles small molecules, biologics, cell/gene therapy, and peptides for pharma customers. FY26 sales growth confirmed at 11–12%. Lower-beta diversified way to own the picks-and-shovels theme without single-peptide concentration. Less GLP-1 leverage but more growth durability.